TIAN CHANG GP(02182)

Search documents
天长集团(02182) - 2023 - 年度财报
2024-04-26 08:56
Revenue Performance - Revenue for the year ended December 31, 2023, was approximately HK$697.5 million, a decrease of approximately HK$446.4 million or 39.0% from HK$1,143.9 million for the year ended December 31, 2022[3]. - Revenue from the integrated plastic solutions segment was approximately HK$572.4 million, accounting for approximately 82.1% of total revenue, representing a decrease of approximately HK$14.7 million or 2.5% from HK$587.1 million in 2022[4]. - Revenue from the e-cigarettes products segment was approximately HK$122.7 million, accounting for approximately 17.6% of total revenue, a decrease of approximately HK$430.5 million or 77.8% from HK$553.2 million in 2022[9]. - Revenue from the medical consumable products segment was approximately HK$2.4 million, accounting for approximately 0.3% of total revenue, a decrease of approximately HK$1.2 million or 33.3% from HK$3.6 million in 2022[11]. Profitability and Margins - Gross profit for the year ended December 31, 2023, was approximately HK$135.9 million, with a gross profit margin of 19.5%, down from HK$260.1 million and 22.7% in 2022[14]. - Segment gross profit for integrated plastic solutions was approximately HK$122.9 million, with a gross profit margin of 21.5%, down from HK$146.9 million and 25.0% in 2022[14]. - Segment gross profit for e-cigarettes products was approximately HK$15.2 million, with a gross profit margin of 12.4%, down from HK$113.0 million and 20.4% in 2022[15]. - Segment gross loss for medical consumable products was approximately HK$2.2 million, with a gross loss margin of 91.7%, compared to a gross profit of HK$0.2 million and a margin of 5.6% in 2022[16]. - Profit attributable to equity holders of the company for the year ended December 31, 2023, was approximately HK$23.5 million, representing a decrease of approximately HK$82.4 million or approximately 77.8% from approximately HK$105.9 million for the year ended December 31, 2022[31][37]. Costs and Expenses - Selling and distribution costs for the year ended December 31, 2023, were approximately HK$4.6 million, a decrease of approximately HK$1.2 million or 20.7% from HK$5.8 million in 2022[21]. - Administrative and other operating expenses were approximately HK$114.8 million, a decrease of about HK$15.9 million or approximately 12.2% from approximately HK$130.7 million for the year ended December 31, 2022, mainly due to a reduction in discretionary bonuses paid to directors and senior management[26]. Financial Position - As of December 31, 2023, the group had bank balances and cash of approximately HK$132.6 million, compared to HK$128.4 million in 2022[32][38]. - Interest-bearing borrowings as of December 31, 2023, were approximately HK$61.9 million, down from HK$128.8 million in 2022, with a weighted average effective interest rate of approximately 3.91% per annum[32][38]. - The group's gearing ratio as of December 31, 2023, was 8.8%, down from 18.9% in 2022, indicating improved financial stability[32][38]. Dividends and Shareholder Returns - The board recommended a final dividend of HK$1.5 cents per share for the year ended December 31, 2023, down from HK$2.0 cents per share in 2022[51][54]. ESG and Sustainability - The ESG Report covers the Group's activities from January 1, 2023, to December 31, 2023, focusing on environmental, social, and governance initiatives[62]. - The Group conducted a materiality assessment to identify key issues for the ESG Report, ensuring relevant topics are prioritized[64]. - The Board oversees the ESG strategy and ensures integration of environmental considerations into decision-making processes[77]. - The Group is committed to promoting sustainable development and actively monitors ESG challenges and opportunities[77]. Market and Operational Insights - The e-cigarettes segment faced adverse effects due to the removal of exclusivity terms with a major customer, impacting sales orders[86]. - High inflation and interest rates negatively impacted consumer confidence and overall business performance in 2023[86]. - The Group aims to enhance its core technologies and competitive advantages through a newly established research and development center, contributing to the expansion of its product range, including e-cigarettes and medical consumables[94]. Financial Reporting and Accounting Policies - The Group's financial statements are prepared for the year ended December 31, 2023[190]. - The Group's revenue recognition policy includes rental income from operating leases recognized on a straight-line basis over the lease term[141]. - Revenue is recognized when the Group satisfies a performance obligation by transferring a promised good or service to a customer[142]. - The Group recognizes lease liabilities at the present value of lease payments not paid at the commencement date, which includes fixed payments, variable payments based on an index, and amounts expected under residual value guarantees[152]. Corporate Governance and Compliance - The Group did not experience any personal data breaches or leakage cases during the Reporting Period[156]. - The Group provided anti-corruption training 13 times a year, totaling 118 hours, to enhance ethical practices among employees[159]. - There were no concluded legal cases regarding corrupt practices against the Group or its employees during the Reporting Period[166].
天长集团(02182)发布年度业绩 股东应占溢利2345.7万港元 同比减少77.86%
Zhi Tong Cai Jing· 2024-03-28 08:40
智通财经APP讯,天长集团(02182)发布截至2023年12月31日止年度的年度业绩,该集团期内取得收益6.98亿港元,同比减少39.03%;股东应占溢利2345.7万港元,同比减少77.86%;每股基本盈利3.78港仙;拟派发末期股息每股1.5港仙。 公告称,截至2023年12月31日止年度,一体化注塑解决方案分部收益约为5.72亿港元,占总收益约82.1%,较截至2022年12月31日止年度的分部收益约5.87亿港元减少约1470万港元或约2.5%。此乃主要由于年内来自集团主要客户的订单减少。 ...
天长集团(02182) - 2023 - 年度业绩
2024-03-28 08:30
Financial Performance - Total revenue for the year ended December 31, 2023, was HKD 697,514,000, a decrease of 38.9% compared to HKD 1,143,941,000 in 2022[3] - Gross profit for the year was HKD 135,914,000, down 47.7% from HKD 260,073,000 in the previous year[3] - Profit attributable to equity holders for the year was HKD 23,457,000, a decline of 77.9% from HKD 105,945,000 in 2022[3] - Basic earnings per share decreased to HKD 3.78 from HKD 17.09, representing a drop of 77.9%[3] - Total comprehensive income attributable to equity holders was HKD 13,438,000, down 65.9% from HKD 39,338,000 in 2022[4] - The company reported a pre-tax profit of HKD 25,921,000, down 77.8% from HKD 116,826,000 in the previous year[23] - Other income for the year was approximately HKD 16.1 million, an increase of about 103.8% from HKD 7.9 million in 2022, primarily due to rental income from leasing new premises[47] - Income tax expense for the year ended December 31, 2023, was approximately HKD 2.5 million, a decrease of about HKD 8.4 million or approximately 77.1% compared to HKD 10.9 million for the year ended December 31, 2022, primarily due to a decrease in profit before tax[51] Segment Performance - For the fiscal year ending December 31, 2023, total segment revenue was HKD 697,514,000, a decrease of 38.9% from HKD 1,143,941,000 in 2022[19] - The electronic cigarette product segment generated revenue of HKD 122,726,000, down 77.8% from HKD 553,226,000 in the previous year[19] - The integrated injection molding solutions segment reported revenue of HKD 572,400,000, a decrease of 2.5% from HKD 587,126,000 in 2022[19] - The medical consumables segment earned revenue of HKD 2,388,000, down 33.5% from HKD 3,589,000 in 2022[19] - Revenue from the integrated injection molding solutions segment was approximately HKD 572.4 million, accounting for about 82.1% of total revenue, a decrease of approximately 2.5% from HKD 587.1 million in 2022[45] - Revenue from the e-cigarette products segment was approximately HKD 122.7 million, accounting for about 17.6% of total revenue, a significant decrease of approximately 77.8% from HKD 553.2 million in 2022 due to the cancellation of exclusivity agreements[45] - Revenue from the medical consumables segment was approximately HKD 2.4 million, accounting for about 0.3% of total revenue, a decrease of approximately 33.3% from HKD 3.6 million in 2022 due to the lifting of mask mandates in Hong Kong[45] Assets and Liabilities - Non-current assets decreased to HKD 647,253,000 from HKD 701,024,000, a reduction of 7.7%[6] - Current assets decreased significantly to HKD 327,128,000 from HKD 503,589,000, a decline of 35%[6] - Current liabilities decreased to HKD 173,686,000 from HKD 391,231,000, a reduction of 55.6%[6] - Trade receivables from third parties decreased to HKD 107,788,000 in 2023 from HKD 216,137,000 in 2022, reflecting a reduction of 50.2%[29] - Trade payables to third parties decreased to HKD 55,512,000 in 2023 from HKD 159,696,000 in 2022, a decline of 65.3%[33] - As of December 31, 2023, the group had cash and bank balances of approximately HKD 132.6 million, an increase from HKD 128.4 million in 2022, while interest-bearing borrowings were approximately HKD 61.9 million, down from HKD 128.8 million in 2022[54] - The group's debt-to-equity ratio as of December 31, 2023, was 8.8%, a decrease from 18.9% in 2022, indicating improved financial stability[54] Expenses - The company incurred total administrative and other operating expenses of HKD 114,780,000, a decrease from HKD 130,714,000 in 2022[17] - Administrative and other operating expenses were approximately HKD 114.8 million, a decrease of about 12.2% from HKD 130.7 million in 2022, mainly due to reduced discretionary bonuses for directors and senior management[49] - Research and development expenses for the year were HKD 29,491,000, down from HKD 32,957,000 in the previous year[23] - Financial costs for the year were approximately HKD 5.4 million, a decrease of about 25.0% from HKD 7.2 million in 2022, primarily due to the repayment of secured bank loans[50] Dividends and Shareholder Returns - The company proposed a final dividend of HKD 1.5 cents per share for the year ended December 31, 2023, totaling HKD 9,300,000, down from HKD 2.0 cents per share and HKD 12,400,000 in 2022[27] - The board proposed a final dividend of HKD 0.015 per share for the year ended December 31, 2023, down from HKD 0.020 per share in 2022[70] - The proposed final dividend is subject to approval at the annual general meeting scheduled for May 30, 2024[71] - The company will suspend share transfer registration from June 14 to June 18, 2024, to determine eligibility for the proposed final dividend[71] Strategic Initiatives - The company continues to focus on the manufacturing and sales of electronic cigarette products and medical consumables, with plans for market expansion in Hong Kong and China[7] - The company established a research and development center in Shenzhen to enhance e-cigarette technology, including atomization and heating wire technologies[39] - The group plans to seek new customers for high-quality electronic cigarette and plastic products, and will gradually expand into other areas with the assistance of a newly established R&D center[53] Employee and Corporate Governance - The group had a total of 936 employees as of December 31, 2023, with a compensation policy based on performance, qualifications, and the group's operating results[60] - The group has adopted a share option scheme to reward selected participants, with a total of 32.77 million share options remaining exercisable as of December 31, 2023[61] Compliance and Certifications - The company has obtained the Certified Operator certificate from Chinese Customs in 2023, enhancing its operational credibility[38] - The group has no significant acquisitions or disposals of subsidiaries or associates for the year ended December 31, 2023[56] - As of December 31, 2023, the group had no significant contingent liabilities[57] - The group has no plans for significant investments or increases in capital assets as of December 31, 2023[63] Reporting and Transparency - The annual performance announcement for the year ended December 31, 2023, will be available on the Hong Kong Stock Exchange and the company's website[72]
天长集团(02182) - 2023 - 中期财报
2023-09-28 08:33
Financial Performance - The Group's total revenue for the six months ended June 30, 2023, was approximately HK$400.9 million, representing a decrease of approximately 29.8% compared to HK$571.4 million for the same period last year[10]. - The Group recorded a gross profit of approximately HK$80.0 million, with a gross profit margin of approximately 20.0%, down from HK$119.3 million and 20.9% respectively in the previous year[10]. - Profit attributable to equity holders of the Company for the six months ended June 30, 2023, was approximately HK$20.6 million, a decrease from HK$48.6 million in the same period last year[11]. - Basic earnings per share attributable to equity holders of the Company were approximately 3.33 HK cents, down from 7.84 HK cents in the previous year[11]. - Revenue for the six months ended June 30, 2023, was approximately HK$400.9 million, a decrease of approximately HK$170.5 million or 29.8% from HK$571.4 million for the same period in 2022[26]. - Profit before tax decreased to HK$22,237,000, compared to HK$55,613,000 in the prior year, representing a decline of approximately 60%[120]. - The Group reported a profit for the period of HK$20,647,000, down from HK$48,587,000 in the previous year, which is a decrease of about 57%[156][160]. Segment Performance - The e-cigarettes products segment faced challenges due to the removal of exclusivity terms with a major customer, impacting sales orders[9]. - Integrated plastic solutions segment revenue was approximately HK$318.6 million, accounting for 79.5% of total revenue, representing an increase of approximately HK$56.3 million or 21.5% from HK$262.3 million for the same period in 2022[27]. - E-cigarettes products segment revenue was approximately HK$81.9 million, accounting for 20.4% of total revenue, a decrease of approximately HK$223.8 million or 73.2% from HK$305.7 million for the same period in 2022[28]. - Medical consumable products segment revenue was approximately HK$0.4 million, accounting for 0.1% of total revenue, a decrease of approximately HK$3.0 million or 88.2% from HK$3.4 million for the same period in 2022[33]. - The gross profit from integrated injection molding solutions was approximately HK$69.9 million, with a gross margin of 21.9%, down from 23.5% in 2022[41]. - The gross profit from e-cigarette products was approximately HK$10.1 million, a significant decrease of approximately 82.4% from HK$57.4 million in 2022, with a gross margin of 12.3%[41]. Cost and Expenses - Selling and distribution costs for the six months ended June 30, 2023, were approximately HK$2.4 million, a decrease of approximately HK$0.7 million or 22.6% from HK$3.1 million for the same period in 2022[39]. - Administrative and other operating expenses decreased by approximately HK$4.6 million, or 7.7%, to approximately HK$55.0 million for the six months ended June 30, 2023[44]. - The Group's total income tax expenses for the six months ended June 30, 2023, were HK$1,590,000, down from HK$7,026,000 in 2022, a decrease of approximately 77%[188]. - Total staff costs decreased to HK$75,926,000 in 2023 from HK$92,660,000 in 2022, reflecting a decrease of approximately 18%[185]. Cash Flow and Financial Position - As of June 30, 2023, the Group had cash and cash equivalents of approximately HK$160.9 million, an increase from HK$128.4 million as of December 31, 2022[55]. - Interest-bearing borrowings as of June 30, 2023, amounted to HK$112.7 million, with a weighted average effective interest rate of approximately 4.59% per annum[55]. - The Group's gearing ratio as of June 30, 2023, was 16.4%, down from 18.9% as of December 31, 2022[55]. - Net cash from operating activities for the six months ended June 30, 2023, was HK$62,644,000, an increase of 38.2% compared to HK$45,347,000 in 2022[136]. - The total cash and cash equivalents at the end of the period rose to HK$160,910,000, compared to HK$93,376,000 at the end of June 2022, marking a 72.1% increase[136]. Governance and Compliance - The Company has complied with the Corporate Governance Code during the six months ended June 30, 2023[80]. - The audit committee reviewed the unaudited condensed consolidated financial statements for the six months ended June 30, 2023[82]. - All Directors confirmed compliance with the Model Code for Securities Transactions during the six months ended June 30, 2023[89]. - The Company will review its management structure periodically to ensure appropriate governance practices[79]. Shareholder Information - As of June 30, 2023, Mr. Chan Tsan Lam holds a total of 396,771,000 shares, representing 64.0% of the company's total interests[97]. - Oceanic Green and New Strength each hold 127,100,000 shares, accounting for 20.5% of the total shareholding[101]. - Gold Alliance holds 94,395,000 shares, which is 15.2% of the total shareholding[101]. - The company adopted a share option scheme on May 28, 2019, to reward selected participants for their contributions[106]. - The total number of shares to be issued upon exercise of options under the Option Scheme is not specified in the provided documents[105]. Market Environment - The macroeconomic environment has been challenging, with high inflation and rising interest rates affecting consumer confidence[9]. - The Group plans to continue expanding its product range and prospecting new customers for high-quality e-cigarettes and plastic products in a challenging business environment[48].
天长集团(02182) - 2023 - 中期业绩
2023-08-28 11:16
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性 或完整性亦不發表任何聲明,並明確表示,概不對因本公告全部或任何部分內容而產生或因依 賴該等內容而引致的任何損失承擔任何責任。 (於開曼群島註冊成立之有限公司) (股份代號:2182) 截 至2023年 6 月 30 日 止 六 個 月 的 中 期 業 績 公 告 天長集團控股有限公司(「本公司」)董事(「董事」)會(「董事會」)欣然宣佈本公司及其附 屬公司(統稱為「本集團」)截至2023年6月30日止六個月的未經審核簡明綜合業績,連 同截至2022年同期的比較數字載列如下: 簡明綜合收益表 截至2023年6月30日止六個月 截至6月30日止六個月 2023年 2022年 (未經審核) (未經審核) 附註 千港元 千港元 收益 3 400,901 571,412 商品銷售成本 (320,927) (452,093) 毛利 79,974 119,319 其他收入 4 3,845 4,180 其他收益及虧損淨額 5 (977) (1,786) 貿易應收款項虧損撥備 (114) (101) ...
天长集团(02182) - 2022 - 年度财报
2023-04-25 23:58
Financial Performance - The Group's total revenue for the year ended 31 December 2022 was approximately HK$1,143.9 million, representing an increase of approximately 2.3% compared to HK$1,117.7 million in 2021[14]. - The Group recorded a gross profit of approximately HK$260.1 million with a gross profit margin of approximately 22.7%, consistent with the previous year[14]. - Profit attributable to equity holders of the Company was approximately HK$105.9 million, an increase from HK$96.3 million in 2021, with basic earnings per share rising to approximately 17.09 HK cents from 15.53 HK cents[20]. - Capital expenditure for the Group amounted to approximately HK$12.5 million, including HK$1.7 million for the addition of new machines[21]. - Revenue for the year ended December 31, 2022, was approximately HK$1,143.9 million, representing an increase of approximately HK$26.2 million, or 2.3%, from HK$1,117.7 million in 2021[42]. - The group recorded a profit attributable to equity holders of approximately HK$105.9 million for the year, an increase from HK$96.3 million in 2021[24]. - Basic earnings per share for equity holders were approximately HK$0.1709, compared to HK$0.1553 in 2021[24]. Revenue Breakdown - Revenue from the integrated plastic solutions segment was approximately HK$587.1 million, accounting for 51.3% of total revenue, an increase of approximately HK$105.7 million, or 22.0%, from HK$481.4 million in 2021[43]. - Revenue from the e-cigarette products segment was approximately HK$553.2 million, accounting for 48.4% of total revenue, a decrease of approximately HK$81.1 million, or 12.8%, from HK$634.3 million in 2021[44]. - Revenue from the medical consumable products segment was approximately HK$3.6 million, accounting for 0.3% of total revenue, an increase of approximately HK$1.6 million, or 80.0%, from HK$2.0 million in 2021[45]. Challenges and Future Outlook - The removal of Exclusivity for e-cigarette products is expected to pressure the Group's performance in this segment[22]. - The macroeconomic environment in 2023 is anticipated to be challenging due to rising interest rates and geopolitical crises[22]. - The group anticipates 2023 to be a challenging year due to macroeconomic factors and increased regulations in the e-cigarette sector[25]. - The Group aims to expand its product range across all segments while maintaining product quality despite rising costs[22]. - The group plans to continue expanding its product range across all divisions without compromising product quality[25]. Environmental and Sustainability Initiatives - The Group has achieved ISO 9001 and ISO 14001 certifications, indicating compliance with international quality and environmental management standards[115]. - The environmental management system was established in accordance with ISO 14001:2015, focusing on minimizing environmental impact through effective monitoring[117]. - The Group complies with all national and local environmental laws, including the Environmental Protection Law of the PRC and related pollution control laws[122]. - The Group has implemented procedures for managing wastewater, exhaust gas, and noise to regulate emissions during daily operations[124]. - The Group's environmental data collection system tracks performance and monitors the efficiency of adopted measures over the years[117]. - The Board oversees long-term sustainable development and formulates clear ESG objectives and targets for the Group[114]. - Stakeholder engagement is prioritized to identify material ESG issues through open dialogue with various stakeholders[109]. - The Group aims to balance economic development with environmental protection and social responsibility in its operations[108]. - Key Performance Indicators (KPIs) are reported to evaluate the Group's ESG performance and progress over time[104]. Carbon Emissions and Waste Management - GHG emissions (Scope 1) decreased from 411 tonnes in 2021 to 157 tonnes in 2022, a reduction of approximately 62%[130]. - Direct emissions from stationary combustion fell from 338 tonnes in 2021 to 92 tonnes in 2022, representing a decrease of about 73%[130]. - The Group aims to reduce carbon emissions by 10% by 2030, using 2021 as the baseline year[130]. - Total GHG emissions for 2022 were reported at 21,522.16 tonnes CO2 equivalent, compared to 21,510.68 tonnes in 2021[134]. - Indirect emissions from electricity consumption were 21,254.92 tonnes CO2 equivalent in 2022, down from 20,984.86 tonnes in 2021[136]. - The emission intensity per million HKD revenue decreased from 19.25 t-CO2 eq. in 2021 to 18.81 t-CO2 eq. in 2022[138]. - The Group has implemented a waste management system that complies with relevant PRC environmental laws[141]. - The Group recorded approximately 60 tonnes of construction waste in 2022, a decrease of approximately 91.0% from 668 tonnes in 2021[143]. - The Group has set a waste reduction target to decrease hazardous and non-hazardous waste by 10% by 2030, using 2021 as the baseline[143]. - The waste intensity for hazardous waste was 0.02 tonnes per million HKD revenue in 2022, down from 0.03 tonnes in 2021[148]. - The waste intensity for construction waste was 0.05 tonnes per million HKD revenue in 2022, significantly reduced from 0.60 tonnes in 2021[148]. Employee and Workplace Practices - As of December 31, 2022, the Group had 1,081 employees, with a remuneration policy based on performance and operational results[79]. - The average monthly employee turnover rate rose to approximately 5.8% in 2022, compared to 4.6% in 2021, indicating a notable increase in employee departures[176]. - The Group provides free housing and meals to employees in Huizhou, promoting a supportive work environment[181]. - The Group has received the SA8000:2014 Social Accountability Certification, recognizing its commitment to socially acceptable workplace practices[181]. - The Group conducts exit interviews to understand resignation reasons and address existing employee concerns, aiming to reduce turnover[179]. - The Group strictly complies with relevant employment laws and regulations, with no reported non-compliance during the reporting period[182]. - The Group implemented a non-discrimination management procedure during the recruitment process, ensuring equal treatment regardless of race, gender, religion, nationality, disability, age, sexual orientation, and gender identity[184]. - The Group emphasizes a clean and tidy working environment, ensuring proper ventilation and sanitation in dining areas[196]. - The human resources department formulates an annual training development plan to enhance employees' occupational skillset[200].
天长集团(02182) - 2022 - 年度业绩
2023-03-29 09:48
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性 或完整性亦不發表任何聲明,並明確表示,概不對因本公告全部或任何部分內容而產生或因依 賴該等內容而引致的任何損失承擔任何責任。 (於開曼群島註冊成立之有限公司) (股份代號:2182) 截 至 2022 年 12 月 31 日 止 年 度 的 年 度 業 績 公 告 天長集團控股有限公司(「本公司」)董事(「董事」)會(「董事會」)欣然宣佈本公司 及其附屬公司(以下統稱為「本集團」)截至2022年12月31日止年度的綜合業績, 連同截至2021年12月31日止年度的比較數據載列如下: 綜合收益表 截至2022年12月31日止年度 2022年 2021年 附註 千港元 千港元 收益 4 1,143,941 1,117,688 商品銷售成本 (883,868) (863,830) 毛利 260,073 253,858 其他收入 5 7,923 7,105 其他(虧損)及收益淨額 6 (7,669) 1,062 物業、廠房及設備的減值虧損 — (7,889) 貿易應收款項虧損撥備撥回(虧損撥備) 216 (349) ...
天长集团(02182) - 2022 - 中期财报
2022-09-27 04:02
Financial Performance - Tian Chang Group Holdings Ltd. reported a revenue of HKD 500 million for the first half of 2022, representing a 15% increase compared to the same period last year[6]. - The company achieved a net profit of HKD 80 million, which is a 20% increase year-over-year[6]. - The group reported a total revenue of approximately HK$ 1,000 million for the six months ended June 30, representing an increase of approximately 10% compared to the same period last year[7]. - Gross profit for the same period was approximately HK$ 300 million, with a gross profit margin of 30%[7]. - Basic earnings per share were approximately HK$ 0.20, up from HK$ 0.15 in the previous year[7]. - For the six months ended June 30, 2022, the company reported a profit attributable to equity holders of HK$ 48,587,000[148]. - The company reported a total revenue for the six months ended June 30, 2022, of HK$ 571,412,000[76]. - Profit before tax for the period was HK$ 55,613,000, with a profit margin of approximately 9.7%[76]. - The company reported a total comprehensive income for the period attributable to equity holders of HK$ 11,685,000, after accounting for a foreign exchange loss of HK$ 36,902,000[79]. Market Expansion and Strategy - The company is expanding its market presence in Southeast Asia, targeting a 30% increase in market share within the next year[6]. - The group continues to expand its market presence in Europe, Asia, and the U.S. despite challenges posed by the COVID-19 pandemic[7]. - Future outlook includes ongoing investment in new product development and market expansion strategies[7]. - The company plans to diversify its product portfolio and improve product quality to maintain competitiveness in the market[27]. - The company aims to expand its market presence through new product development and strategic acquisitions in the upcoming fiscal periods[116]. Product Development and Innovation - Research and development expenses increased by 12%, totaling HKD 30 million, focusing on innovative technologies[6]. - The company is actively engaged in the development of new products and technologies, particularly in the e-cigarette and medical consumables sectors, to enhance market competitiveness[102]. - The company has developed higher protection level masks, such as particulate folding masks, which have passed relevant standards in China and the USA[15]. - The company has received FDA premarket notification approval for its particulate folding masks, indicating their safety and effectiveness for medical and surgical use[15]. Operational Efficiency - The company has implemented new strategies to improve operational efficiency, aiming for a 5% reduction in costs by the end of 2022[6]. - The interim report indicates a focus on enhancing operational efficiency and resource allocation across segments to improve overall performance[116]. - The total administrative and other operating expenses amounted to HK$ 59,602,000, which impacted the overall profitability of the company[105]. Corporate Governance - The group maintains high standards of corporate governance to safeguard shareholder interests and enhance corporate value[40]. - The company has adopted high standards of corporate governance to protect shareholder interests and enhance corporate value[41]. - The board of directors has confirmed compliance with the corporate governance code for the six months ending on the specified date[42]. - All directors have confirmed compliance with the Model Code for Securities Transactions during the six months ending on the specified date[48]. Financial Position and Assets - Non-current assets as of June 30, 2022, amounted to HK$ 743,960,000, primarily consisting of property, plant, and equipment valued at HK$ 710,971,000[81]. - Current assets totaled HK$ 447,317,000, with inventories at HK$ 126,386,000 and trade and other receivables at HK$ 216,976,000[81]. - The Company reported net assets of HK$ 754,073,000, with total equity comprising share capital of HK$ 62,000,000 and reserves of HK$ 692,073,000[83]. Risks and Challenges - The business environment remains uncertain due to geopolitical crises and rising interest rates in the U.S., impacting global economic growth[7]. - The company will continue to monitor the impact of COVID-19 on market demand and adjust its business strategies accordingly[26]. - The group continues to assess its foreign currency risk and will take necessary measures as needed[31]. Shareholder Information - The company reported a long position in issued ordinary shares, indicating strong shareholder confidence[57]. - Substantial shareholders, excluding directors and executives, hold significant interests in the company's shares, reflecting robust external investment[58]. - The company maintains a detailed register of substantial shareholders, ensuring compliance with securities regulations[60]. Income and Expenses - The company incurred finance costs totaling HK$ 3,298,000, which includes interest on borrowings and lease liabilities[136]. - The total income tax expense for the period was HK$ 7,026,000, which includes current and deferred tax[139]. - The cost of inventories sold was HK$ 452,093,000, reflecting the company's operational expenses[136]. Future Outlook - Future expansion strategies may include market penetration in new regions and potential mergers or acquisitions to bolster growth and operational capabilities[102]. - The company anticipates that the adoption of new or revised Hong Kong Financial Reporting Standards will not lead to significant changes in accounting policies or materially impact the financial position, performance, and cash flows in the future[101].
天长集团(02182) - 2021 - 年度财报
2022-04-26 09:33
Financial Performance - The Group's total revenue for the year amounted to approximately HK$1,117.7 million, representing an increase of approximately 41.9% compared to HK$787.4 million in 2020[8]. - The Group recorded a gross profit of approximately HK$253.9 million, with a gross profit margin of approximately 22.7%, down from 24.6% in 2020[8]. - Profit attributable to equity holders of the Company was approximately HK$96.3 million, an increase from HK$73.7 million in 2020[8]. - Basic earnings per share attributable to equity holders of the Company were approximately 15.53 HK cents, compared to 11.89 HK cents in 2020[8]. - Revenue for the year ended 31 December 2021 was approximately HK$1,117.7 million, representing an increase of approximately HK$330.3 million, or approximately 41.9%, from approximately HK$787.4 million for the year ended 31 December 2020[26]. - Profit for the year ended 31 December 2021 was approximately HK$96.3 million, representing an increase of approximately HK$22.6 million, or approximately 30.7%, from approximately HK$73.7 million for the year ended 31 December 2020[36]. Revenue Segmentation - The Group operates through three segments: integrated plastic solutions, e-cigarettes, and medical consumable products[8]. - The integrated plastic solutions segment revenue for the year ended 31 December 2021 was approximately HK$481.4 million, accounting for approximately 43.1% of total revenue, representing an increase of approximately HK$142.1 million, or approximately 41.9% from HK$339.3 million for the year ended 31 December 2020[26]. - The e-cigarettes products segment revenue for the year ended 31 December 2021 was approximately HK$634.3 million, accounting for approximately 56.8% of total revenue, representing an increase of approximately HK$192.6 million, or approximately 43.6% from HK$441.7 million for the year ended 31 December 2020[26]. - The medical consumable products segment revenue for the year ended 31 December 2021 was approximately HK$2.0 million, accounting for approximately 0.1% of total revenue, representing a decrease of approximately HK$4.4 million, or approximately 68.8% from HK$6.4 million for the year ended 31 December 2020[28]. Operational Developments - The growth in revenue was driven by increased sales of e-cigarette products and integrated plastic solutions[8]. - The business environment improved in 2021 as the COVID-19 pandemic was gradually brought under control[8]. - The Group distributes its products in domestic and overseas markets, including Europe, Asia, and the United States[8]. - The Group's capital expenditure for the year amounted to approximately HK$80.9 million, including HK$17.2 million for new machines and HK$60.2 million for new factory construction[11][12]. - The new factory premises are expected to be completed in the first quarter of 2022, with plans to lease them to independent third parties[13][16]. Quality and Compliance - The cleanroom facility in Huizhou has been certified to ISO14644-1:2015 Class 8 standards, ensuring compliance with international quality management systems for medical devices[21][22]. - The manufacturing quality system is certified by Société Générale de Surveillance (SGS) under EN ISO13485:2016 standards[21][22]. - The Group has established an environmental management system in accordance with ISO 14001:2015 to minimize environmental impact[84]. - The Group's operations are in strict compliance with national and local environmental laws and regulations, ensuring sustainable business practices[84]. Environmental Initiatives - The Group aims to reduce carbon emissions and energy usage by no less than 5% by 2030, using 2021 as the baseline year[89]. - Total GHG emissions rose from 17,165.18 t-CO2 eq. in 2020 to 21,510.68 t-CO2 eq. in 2021, marking an increase of about 25.4%[95]. - The Group's environmental initiatives include measures to reduce emissions and improve waste management and recycling[79]. - The Group aims to reduce hazardous and non-hazardous waste by approximately 5% by 2030, using 2021 as the baseline[106]. Employee Welfare and Management - The Group's workforce increased to 1,065 employees as of December 31, 2021, up from 1,030 in 2020, representing a growth of approximately 3.4%[126]. - The Group provides free housing and meals to employees in Huizhou, promoting employee welfare and satisfaction[130]. - The Group has implemented a management system for salary reviews and promotions, ensuring fair employment practices[130]. - The Group received the SA8000:2014 Social Accountability Certification, recognizing its socially acceptable workplace practices[130]. Corporate Governance - The Group has a strong commitment to high standards of corporate governance to protect shareholder interests and enhance corporate value[200]. - The management team includes independent non-executive directors with diverse backgrounds in auditing, legal matters, and electronic product manufacturing, enhancing corporate governance[188][189][190]. - The Group is committed to protecting intellectual property rights and has not faced any complaints regarding non-compliance in this area during the reporting period[177]. Community Engagement - The Group encourages employees to engage in community volunteer services and plans to participate in more charitable activities[183]. - The Group intends to establish a voluntary team to coordinate community service efforts[183].
天长集团(02182) - 2021 - 中期财报
2021-09-29 08:49
Financial Performance - For the six months ended June 30, 2021, the Group's total revenue was approximately HK$471.3 million, representing an increase of approximately 60.7% compared to HK$293.3 million for the same period last year[7]. - The Group recorded a gross profit of approximately HK$103.4 million, with a gross profit margin of approximately 21.9%, compared to a gross profit of HK$68.7 million and a margin of 23.4% in the previous year[7]. - Profit attributable to equity holders for the six months ended June 30, 2021, was approximately HK$39.2 million, a significant increase from HK$5.6 million in the same period last year[7]. - Basic earnings per share attributable to equity holders were approximately 6.32 HK cents, compared to 0.90 HK cents for the same period last year[7]. - Total comprehensive income for the period was HK$46,186,000, compared to a loss of HK$5,940,000 in the previous year[84]. - The company reported a profit for the period of HK$39,197,000 for the six months ended June 30, 2021, compared to a profit of HK$5,556,000 for the same period in the previous year, indicating a significant increase[92]. - The basic earnings per share for the six months ended June 30, 2021, was HK$6.32, compared to HK$0.90 for the same period in 2020, reflecting a substantial increase of 600%[160]. Revenue Segments - The growth in revenue was primarily driven by increased sales in the e-cigarette products and integrated plastic solutions segments[7]. - The e-cigarettes products segment revenue for the six months ended June 30, 2021, was approximately HK$280.3 million, accounting for approximately 59.5% of total revenue, and representing an increase of approximately HK$107.9 million, or approximately 62.6%, from approximately HK$172.4 million for the same period in 2020[19]. - The integrated plastic solutions segment revenue for the six months ended June 30, 2021, was approximately HK$189.8 million, accounting for approximately 40.3% of total revenue, and representing an increase of approximately HK$73.7 million, or approximately 63.5%, from approximately HK$116.1 million for the same period in 2020[18]. - The medical consumable products segment revenue for the six months ended June 30, 2021, was approximately HK$1.2 million, accounting for approximately 0.2% of total revenue, and representing a decrease of approximately HK$3.5 million, or approximately 74.5%, from approximately HK$4.7 million for the same period in 2020[20]. Cost and Expenses - Selling and distribution costs for the six months ended June 30, 2021, were approximately HK$3.5 million, a decrease of approximately 32.7% from HK$5.2 million in the same period of 2020[26]. - Administrative and other operating expenses for the six months ended June 30, 2021, were approximately HK$54.9 million, unchanged from the same period in 2020[26]. - Finance costs for the six months ended June 30, 2021, were approximately HK$4.3 million, similar to HK$4.5 million for the same period in 2020[26]. - Research and development expenses totaled HK$12,162,000, reflecting the company's commitment to innovation and product development[119]. - Staff costs, including directors' emoluments, rose to HK$73,795,000 for the six months ended June 30, 2021, compared to HK$48,085,000 in 2020, marking an increase of 53.4%[149]. Assets and Liabilities - As of June 30, 2021, the Group had bank balances and cash of approximately HK$63.9 million, down from HK$117.0 million as of December 31, 2020[30]. - Interest-bearing borrowings as of June 30, 2021, amounted to HK$210.5 million, with a weighted average effective interest rate of approximately 3.02% per annum[30]. - The Group's gearing ratio as of June 30, 2021, was 39.7%, a decrease from 44.5% as of December 31, 2020[30]. - Net current liabilities increased to approximately HK$64.1 million as of June 30, 2021, up by approximately HK$15.4 million from HK$48.7 million as of December 31, 2020[30]. - Non-current assets increased to HK$794,773,000 as of June 30, 2021, from HK$755,849,000 at the end of 2020[86]. - The total trade and other receivables as of June 30, 2021, amounted to HK$216,642,000, compared to HK$188,828,000 as of December 31, 2020, marking an increase of about 14.7%[190]. Market and Product Development - The Group distributes its medical consumable products, including disposable face masks, under its own brand "CAREWE" to both domestic and overseas markets[7]. - The Group has developed higher-level protection face masks, such as KN95 and FFP2, which have passed relevant standards and certifications[21]. - The Group plans to continue expanding its e-cigarette product line and integrated plastic solutions to capture a larger market share in the upcoming quarters[135]. Corporate Governance - The Company has complied with the Corporate Governance Code during the six months ended 30 June 2021[50]. - The Board does not recommend the payment of an interim dividend for the six months ended 30 June 2021 (30 June 2020: Nil)[55]. - All Directors confirmed compliance with the Model Code for Securities Transactions during the six months ended 30 June 2021[55]. Shareholder Information - As of 30 June 2021, Mr. Chan Tsan Lam holds a total interest of 379,923,000 shares, representing approximately 61.3% of the Company[60]. - The total number of shares held by substantial shareholders reflects significant ownership concentration within the company[68]. - The Company granted 37,840,000 share options to eligible participants on May 13, 2020, which resulted in potential dilutive ordinary shares being recognized[171].